Results 71 to 80 of about 687 (166)

Alopecia universalis after injection of messenger RNA COVID-19 vaccine. A case report

open access: yesIDCases, 2023
Messenger RNA vaccines against SARS-CoV-2 infection, or COVID-19 dramatically changed the landscape of the fight against COVID-19 pandemic. However, they might be associated with various side effects, such as myocarditis.
Kentaro Iwata, Makoto Kunisada
doaj  

Molecular signatures define alopecia areata subtypes and transcriptional biomarkers

open access: yesEBioMedicine, 2016
Alopecia areata (AA) is an autoimmune disease typified by nonscarring hair loss with a variable clinical course. In this study, we conducted whole genome gene expression analysis of 96 human scalp skin biopsy specimens from AA or normal control subjects.
Ali Jabbari   +9 more
doaj   +1 more source

An endocrinopathy characterized by dysfunction of the pituitary-adrenal axis and alopecia universalis: supporting the entity of a triple H syndrome [PDF]

open access: bronze, 2002
Kenji Ichiki   +6 more
openalex   +1 more source

Trends in Prevalence and Incidence of Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Among Adults and Children in a US Employer-Sponsored Insured Population [PDF]

open access: hybrid, 2023
Arash Mostaghimi   +7 more
openalex   +1 more source

Effect of cannabis use on alopecia areata

open access: yesRevista da Sociedade Portuguesa de Dermatologia e Venereologia, 2023
Introduction: Alopecia areata (AA) is an autoimmune disease of the hair follicles causing unpredictable hair loss, occurring in about 2% of the general population throughout their lifetime.
Abeer AL Lihabi
doaj  

Autoimmune Polyglandular Syndrome Type 2 Presentation with Alopecia Universalis, Hashimoto’s Disease, and Addison’s Disease

open access: yesInternational Medical Case Reports Journal
Karla Denisse Sales-Morales,1,* Nazhira Torres-Neme,2 Vladimir Barrera-Villanueva,3 Alejandro Martínez-Carreón1,* 1Department of Internal Medicine, High Specialty Regional Hospital, ISSSTE, Veracruz, Mexico; 2Department of Endocrinology ...
Sales-Morales KD   +3 more
doaj  

Diphenylcyclopropenone in severe alopecia areata in children and adolescents: long-term follow-up and relapse rate

open access: yesJournal of the Egyptian Women’s Dermatologic Society
Background Reports on the long-term treatment of alopecia areata (AA) in children with diphenylcyclopropenone (DPCP) are few. Objective To assess response, side effects, and relapse rates during long-term follow-up in children with severe AA treated with
Yasmin B. El Zawahry   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy